Related Articles
Clinical and molecular assessment of regorafenib monotherapy
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer
Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy
Transcriptional profiling of circulating tumor cells: Quantification and cancer progression (Review)
Amplification of mutant <em>KRAS</em><sup>G12D</sup> in a patient with advanced metastatic pancreatic adenocarcinoma detected by liquid biopsy: A case report